Feeds › Congressional trades
Congressional trades
Stock trades disclosed by members of the House and Senate under the STOCK Act.
About this data
- What it is
- Under the STOCK Act, members of the House and Senate must disclose stock trades over $1,000 made by themselves, their spouses and their dependent children. They report each trade as a dollar range, such as $1,001–$15,000, not an exact amount.
- Who files it
- Each member, on a periodic transaction report (PTR) filed with the House Clerk or the Senate.
- How current
- Members have up to 45 days to report a trade, so some trades appear weeks after they happened. We collect new House reports every few hours and Senate reports once a day.
- Worth knowing
- The ranges are wide, and a spouse's trade is not necessarily the member's own decision. We match assets to companies automatically, so check the filing before relying on a single row. A few rows dated after their own filing, usually a misread scan, are left out. Senate trades come from an independent public copy of the Senate's electronic filings, because the Senate's own site doesn't allow automated access. Each one links to the official report. The copy starts with reports filed in 2014, leaves out paper filings, and is missing a small share of lines, so a senator's list can be incomplete. Committee overlap describes jurisdiction only; it does not show that a trade was improper. It uses committee assignments in the 119th Congress and checks trades dated since 3 January 2025.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Trades disclosed per day, last 30 days
Purchases Sales
By the day the report was filed. The trades themselves can be up to 45 days older.
Latest congressional trades
Showing: ticker VRSN
| Traded | Filed | Member | Stock | Type | AmountMembers of Congress report each trade as a dollar range, such as $1,001–$15,000, not an exact amount. | Owner | Filing |
|---|---|---|---|---|---|---|---|
| Mar 30, 2026 | Jul 21, 2026 | Alan Armstrong Republican Senate · OK | VRSN VeriSign, Inc. | Purchase | $1,001 - $15,000 | Member | Report ↗ |
| Mar 13, 2026 | Apr 7, 2026 | Gilbert Ray Cisneros, Jr. Democrat House · CA | VRSN VeriSign, Inc. | Sale (partial) | $1,001 - $15,000 150 Main Street Trust > Bank of America | Member | Report ↗ |
| Feb 10, 2026 | Mar 9, 2026 | Gilbert Ray Cisneros, Jr. Democrat House · CA | VRSN VeriSign, Inc. | Purchase | $1,001 - $15,000 150 Main Street Trust > Bank of America | Member | Report ↗ |
| Dec 19, 2025 | Jan 12, 2026 | Gilbert Ray Cisneros, Jr. Democrat House · CA | VRSN VeriSign, Inc. | Purchase | $1,001 - $15,000 150 Main Street Trust > Bank of America | Member | Report ↗ |
| Oct 6, 2025 | Nov 14, 2025 | Julie Johnson Democrat House · TX | VRSN VeriSign, Inc. | Sale | $1,001 - $15,000 Merrill Lynch Long Term Growth | Joint account | Report ↗ |
| Oct 3, 2025 | Aug 5, 2026 | Julie Johnson Democrat House · TX | VRSN VeriSign, Inc. | Sale | $1,001 - $15,000 Merrill Lynch Tax Efficient Core | Joint account | Report ↗ |
| Oct 3, 2025 | Aug 5, 2026 | Julie Johnson Democrat House · TX | VRSN VeriSign, Inc. | Purchase | $1,001 - $15,000 Merrill Lynch Long Term Growth | Joint account | Report ↗ |
| Jul 3, 2025 | Aug 11, 2025 | James Comer Republican House · KY | VRSN VeriSign, Inc. | Sale (partial) | $1,001 - $15,000 | Member | Report ↗ |
| Jun 24, 2025 | Aug 13, 2025 | Lisa C. McClain Republican House · MI | VRSN VeriSign, Inc. | Sale | $1,001 - $15,000 Charles Schwab Brokerage Account 924 | Spouse | Report ↗ |
| Jun 17, 2025 | Aug 13, 2025 | Lisa C. McClain Republican House · MI | VRSN VeriSign, Inc. | Purchase | $1,001 - $15,000 Charles Schwab Brokerage Account 924 | Spouse | Report ↗ |
| Jan 2, 2025 | Jan 10, 2025 | James Comer Republican House · KY | VRSN VeriSign, Inc. | Purchase | $1,001 - $15,000 | Member | Report ↗ |
| Jun 10, 2021 | Jul 20, 2021 | William R. Keating Democrat House · MA | VRSN VeriSign, Inc. | Sale | $1,001 - $15,000 Bill's IRA | Member | Report ↗ |
| Apr 14, 2021 | Apr 27, 2021 | William R. Keating Democrat House · MA | VRSN VeriSign, Inc. | Purchase | $1,001 - $15,000 Bill's IRA | Member | Report ↗ |
| Mar 17, 2021 | Apr 27, 2021 | William R. Keating Democrat House · MA | VRSN VeriSign, Inc. | Purchase | $1,001 - $15,000 Bill's IRA | Member | Report ↗ |
| Sep 23, 2020 | Oct 9, 2020 | Dean Phillips Democrat House · MN | VRSN VeriSign, Inc. | Purchase | $1,001 - $15,000 | Member | Report ↗ |
| Mar 18, 2020 | Apr 16, 2020 | Gilbert Ray Cisneros, Jr. Democrat House · CA | VRSN VeriSign, Inc. | Purchase | $1,001 - $15,000 150 Main Street Trust > U.S. Trust Holdings | Member | Report ↗ |
| Apr 25, 2019 | May 9, 2019 | Susie Lee Democrat House · NV | VRSN VeriSign, Inc. | Sale | $1,001 - $15,000 DSL Living Trust > Bank of New York Brokera… | Joint account | Report ↗ |
| Aug 10, 2017 | Aug 13, 2018 | Josh Gottheimer Democrat House · NJ | VRSN VeriSign, Inc. | Sale | $1,001 - $15,000 Morgan Stanley - Select UMa account # 1 | Joint account | Report ↗ |
18 items, most recent first (up to 50). Every row links to its original filing. Committee overlap describes jurisdiction only; it does not show that a trade was improper. Based on committee assignments in the 119th Congress (since 3 January 2025). Only trades in listed companies dated since then are checked, and only clear, named jurisdictions count. Updated Nov 15, 2026, 5:33 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances